20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 5 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) |
---|---|---|---|---|---|
640 | 13 | 233 | 2,577 | 27 | 327 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, WB; Falck, JR; Kurian, JB; Pratt, PF; Reddy, KM | 1 |
Hirt, J; Qiu, Y; Quilley, J | 1 |
Ahluwalia, A; Chauhan, S; Davis, C; De Felipe, C; Hunt, S; Kabir, J; Kotsonis, P; Oh, U; Scotland, RS | 1 |
Busse, R; Falck, JR; Fleming, I; Kiss, L; Randriamboavonjy, V | 1 |
Falck, JR; Fang, X; Faraci, FM; Harmon, S; Hu, S; Kaduce, TL; Modrick, ML; Moore, SA; Spector, AA; Weintraub, NL | 1 |
5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
20-HETE relaxes bovine coronary arteries through the release of prostacyclin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Cattle; Coronary Vessels; Epoprostenol; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Isometric Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Vasodilation | 1998 |
Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mixed Function Oxygenases; Nitroarginine; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Capsaicin; Cation Transport Proteins; CHO Cells; Cricetinae; Endothelium, Vascular; Gadolinium; Ganglia, Sympathetic; Guanethidine; Hydroxyeicosatetraenoic Acids; Ion Channels; Male; Mesenteric Arteries; Mice; Mice, Knockout; Models, Cardiovascular; Models, Neurological; Nerve Fibers, Unmyelinated; Nociceptors; Peptides, Cyclic; Piperidines; Pressure; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Ruthenium Red; Sodium Channel Blockers; Splanchnic Circulation; Stress, Mechanical; Sympathectomy, Chemical; Tetrodotoxin; TRPV Cation Channels; Vascular Resistance; Vasoconstriction | 2004 |
The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Animals; Aryl Hydrocarbon Hydroxylases; Biological Factors; Coronary Vessels; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Mixed Function Oxygenases; Protein Kinase C; Sulfones; Swine; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Basilar Artery; Cell Culture Techniques; Cells, Cultured; Cyclooxygenase Inhibitors; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Indomethacin; Mice; Mice, Inbred C57BL; Prostaglandin-Endoperoxide Synthases; Telencephalon; Vasoconstrictor Agents; Vasodilation | 2006 |